• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Parshva Enterprises Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
542694
INE05MV01019
10.5593857
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
175.16
EPS(TTM)
Face Value()
Div & Yield %
0.29
10
0
 

Kabra Drugs standalone net profit rises 171.79% in the March 2026 quarter
May 30,2026
Net profit of Kabra Drugs rose 171.79% to Rs 1.06 crore in the quarter ended March 2026 as against Rs 0.39 crore during the previous quarter ended March 2025. Sales reported to Rs 35.41 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 4.96 crore in the year ended March 2026 as against net loss of Rs 1.09 crore during the previous year ended March 2025. Sales reported to Rs 92.74 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales35.410 0 92.740 0
OPM %3.780 -5.760 -
PBDT1.440.40 260 5.80-1.08 LP
PBT1.420.39 264 5.73-1.09 LP
NP1.060.39 172 4.96-1.09 LP